Exercise can counter the detrimental effects of cancer treatment, such as heart and nerve damage and brain fog, suggests an ...

A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

Smoking status added to the National Cancer Database for patients diagnosed with cancer in 2023 revealed variations in ...

Patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation experienced ...

AstraZeneca Partners with Revna Biosciences to Enhance Epidermal Growth Factor Receptor (EGFR) Biomarker Testing in Ghana ...

Li Qiang, director of the respiratory and critical care medicine department at the hospital, said the patient had over 10 ...